Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients (SOSTA)

AstraZeneca

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00727883

NIS-OIT-DUM-2006/1

Details and patient eligibility

About

Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients

Enrollment: 190 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs
• Documented reasons for treatment withdrawal

Exclusion criteria

• enrollment in other studies
• treatment withdraw for other causes than Tam related AEs

Trial design

190 participants in 1 patient group

1

Description:

Post menopausal women treated with adjuvant TAM for breast cancer